Treatment of Corneal Neovascularization Using Anti-VEGF Bevacizumab

林念庭（2008）。Inhibitory Effect of Anti-VEGF Drugs Bevacizumab (Avastin) on Corneal Neovascularization〔碩士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2008.00391
Segal, K. L., Fleischut, P. M., Kim, C., Levine, B., Faggiani, S. L., Banerjee, S., Gadalla, F., & Jr., G. J. L. (2014). Evaluation and Treatment of Perioperative Corneal Abrasions. Journal of Ophthalmology, (2014-4), 142-146. https://doi.org/10.1155/2014/901901
Lo, Y. L., & Hu, C. C. (2010). Intravitreal Bevacizumab for Treating Exudative Retinal Detachment in Coats Disease. 輔仁醫學期刊, 8(4), 183-189. https://www.airitilibrary.com/Article/Detail?DocID=18102093-201012-201109140013-201109140013-183-189
朱雲華、黃書紳、劉榮宏、林嘉理、林振隆（1988）。Subretinal Neovascularization Following Argon Laser Photocoagulation for Central Serous Chorioretinopathy。中華民國眼科醫學會雜誌，27(2)，800-804。https://doi.org/10.30048/ACTASOS.198805.0140
Yoshida, J., Wicks, R. T., Zambrano, A. I., Tyler, B. M., Javaherian, K., Grossman, R., Daoud, Y. J., Gehlbach, P., Brem, H., & Stark, W. J. (2015). Inhibition of Corneal Neovascularization by Subconjunctival Injection of Fc-Endostatin, a Novel Inhibitor of Angiogenesis. Journal of Ophthalmology, 2015(), 71-78. https://doi.org/10.1155/2015/137136